FDA Enforcement Class II Ongoing

Sprotte Needle, REF 33115131B w/ Intro 20 G x 3.5", distributed by Teleflex Medical The SPROTTE lumbar puncture needles are intended to gain entry into or puncture the spinal cavity permitting injection (including anesthesia) / withdrawal of fluids for purposes of diagnostic lumbar puncture, myelography/discography procedures.

Recall: Z-2130-2020 · Reported June 3, 2020

Enforcement

Recall Number
Z-2130-2020
Event ID
85551
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
TELEFLEX MEDICAL INC
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
June 3, 2020
Initiation Date
October 11, 2019
Classification Date
May 26, 2020
Address
3015 Carrington Mill Blvd, N/A, Morrisville, NC, 27560-5437, United States

Description

Sprotte Needle, REF 33115131B w/ Intro 20 G x 3.5", distributed by Teleflex Medical The SPROTTE lumbar puncture needles are intended to gain entry into or puncture the spinal cavity permitting injection (including anesthesia) / withdrawal of fluids for purposes of diagnostic lumbar puncture, myelography/discography procedures.

Reason

Teleflex received the attached Medical Device Recall Notice from Pajunk Medical. Teleflex Medical is a distributor of Pajunk products. According to the notice, Pajunk internally identified a packaging problem that may affect certain batches of the SPROTTE lumbar puncture cannulas with introducer. Due to this problem Pajunk cannot guarantee the sterility of the affected batches.

Code Info

Lot/Batch Numbers: 74A1900703, 74D1802540, 74E1800978, 74F1801413, 74G1800896, 74H1800162, 74K1801738, 74K1802909, 74L1800502

Distribution

Nationwide distribution.

Quantity

800 devices